Beijing Science Sun Pharmaceutical (300485.SZ) Shareholders Ma Li and Liu Shuqin plan to collectively reduce their shareholding by no more than 2%.
Saisheng Pharmaceutical (300485.SZ) announced that company shareholders Ms. Ma Li and Ms. Liu Shuqin plan to increase their holdings by 1% each in the company by January 2025.
Beijing Science Sun Pharmaceutical (300485.SZ) announcement, company shareholders Ms. Ma Li and Ms. Liu Shuqin plan to reduce their total shareholding in the company by no more than 9.6333 million shares through centralized bidding and block trading methods from October 21, 2025 to January 20, 2026, that is, not exceeding 2% of the company's current total share capital.
Related Articles
GALA TECH HOLD (02458) adopts the 2025 share incentive plan.
US Stock Market Move | Brera Holdings (BREA.US) soars 43% with investment from "Wood Sister" and UAE investors
Cheuk Nang Holdings (00131) issues profit warning, expecting annual loss attributable to shareholders of approximately HK$980 million to HK$1.1 billion.
GALA TECH HOLD (02458) adopts the 2025 share incentive plan.
US Stock Market Move | Brera Holdings (BREA.US) soars 43% with investment from "Wood Sister" and UAE investors
Cheuk Nang Holdings (00131) issues profit warning, expecting annual loss attributable to shareholders of approximately HK$980 million to HK$1.1 billion.
RECOMMEND
Three-Year R&D Spend Drains RMB 2.4 Billion, Urgent Cash Needs Drive Maiwei Biotech Back to Hong Kong Amid Compliance Scrutiny
18/09/2025
Why Generating Profit Remains Challenging for Lidar Companies
18/09/2025
SEC Adopts Landmark Rule to Restrict Shareholder Class Actions in Bid to Revive IPO Market
18/09/2025
